Exploratory trial of the systemic application of CIGB-128 (HeberPAG(R)) in Mycosis Fungoides, stages Ib to III

Trial Profile

Exploratory trial of the systemic application of CIGB-128 (HeberPAG(R)) in Mycosis Fungoides, stages Ib to III

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs Interferon-alpha-2b/interferon-gamma (Primary)
  • Indications Mycosis fungoides
  • Focus Adverse reactions
  • Acronyms MYFIC
  • Most Recent Events

    • 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry record.
    • 11 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top